6.
Arango Duque G, Descoteaux A
. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014; 5:491.
PMC: 4188125.
DOI: 10.3389/fimmu.2014.00491.
View
7.
Jia S, Guo X, Chen Z, Li S, Liu X
. The roles of the circadian hormone melatonin in drug addiction. Pharmacol Res. 2022; 183:106371.
DOI: 10.1016/j.phrs.2022.106371.
View
8.
Crews F, Zou J, Qin L
. Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun. 2011; 25 Suppl 1:S4-S12.
PMC: 3552373.
DOI: 10.1016/j.bbi.2011.03.003.
View
9.
Chilunda V, Weiselberg J, Martinez-Meza S, Mhamilawa L, Cheney L, Berman J
. Methamphetamine induces transcriptional changes in cultured HIV-infected mature monocytes that may contribute to HIV neuropathogenesis. Front Immunol. 2022; 13:952183.
PMC: 9433802.
DOI: 10.3389/fimmu.2022.952183.
View
10.
Harms R, Morsey B, Boyer C, Fox H, Sarvetnick N
. Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppression. PLoS One. 2012; 7(12):e49897.
PMC: 3515581.
DOI: 10.1371/journal.pone.0049897.
View
11.
Fitzgerald P
. Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo. Int J Mol Sci. 2021; 22(19).
PMC: 8509043.
DOI: 10.3390/ijms221910706.
View
12.
Canedo T, Portugal C, Socodato R, Almeida T, Terceiro A, Bravo J
. Astrocyte-derived TNF and glutamate critically modulate microglia activation by methamphetamine. Neuropsychopharmacology. 2021; 46(13):2358-2370.
PMC: 8581027.
DOI: 10.1038/s41386-021-01139-7.
View
13.
Coller J, Hutchinson M
. Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacol Ther. 2012; 134(2):219-45.
DOI: 10.1016/j.pharmthera.2012.01.008.
View
14.
Vishwakarma S, Singh S, Singh T
. Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis. Mol Biol Rep. 2021; 49(2):1437-1452.
DOI: 10.1007/s11033-021-06896-8.
View
15.
Chen Z, Jalabi W, Hu W, Park H, Gale J, Kidd G
. Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain. Nat Commun. 2014; 5:4486.
PMC: 4109015.
DOI: 10.1038/ncomms5486.
View
16.
Bortell N, Basova L, Semenova S, Fox H, Ravasi T, Marcondes M
. Astrocyte-specific overexpressed gene signatures in response to methamphetamine exposure in vitro. J Neuroinflammation. 2017; 14(1):49.
PMC: 5345234.
DOI: 10.1186/s12974-017-0825-6.
View
17.
Kalayasiri R, Dadwat K, Thika S, Sirivichayakul S, Maes M
. Methamphetamine (MA) use and MA-induced psychosis are associated with increasing aberrations in the compensatory immunoregulatory system, interleukin-1α, and CCL5 levels. Transl Psychiatry. 2023; 13(1):361.
PMC: 10667231.
DOI: 10.1038/s41398-023-02645-6.
View
18.
Locati M, Curtale G, Mantovani A
. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2019; 15:123-147.
PMC: 7176483.
DOI: 10.1146/annurev-pathmechdis-012418-012718.
View
19.
Karimi-Haghighi S, Chavoshinezhad S, Mozafari R, Noorbakhsh F, Borhani-Haghighi A, Haghparast A
. Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review. Cell Mol Neurobiol. 2022; 43(2):649-682.
PMC: 11415174.
DOI: 10.1007/s10571-022-01223-6.
View
20.
Shaerzadeh F, Streit W, Heysieattalab S, Khoshbouei H
. Methamphetamine neurotoxicity, microglia, and neuroinflammation. J Neuroinflammation. 2018; 15(1):341.
PMC: 6292109.
DOI: 10.1186/s12974-018-1385-0.
View